Capital Markets & Financing
Adlai Norty has filed F-1 with the US SEC for the company to be listed in the US in late July
Adlai Nortye, headquartered in Hangzhou, China and with an office in New Jersey, USA, has filed F-1 with the US SEC for the company to be listed in the US in late July. Cantor is the lead underwriter and CLSA is a co-manager
Novo Holdings Increases Investment in Halodoc to Strengthen Indonesia’s Health System
Novo Holdings today announced that it has increased its investment in Halodoc, an Indonesia-based healthtech platform, by joining the US $135 million Series D funding round led by Astra International Tbk (Astra).
House committee quizzes BlackRock and MSCI on China investments
The US House of Representatives China committee has accused BlackRock and MSCI of profiting from investments that help the Chinese military and undermine American values and security.
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq Global Market.
HKEX Signs Cooperation Agreement with Indonesia Stock Exchange
Hong Kong Exchanges and Clearing Limited (HKEX) is today (Wednesday) pleased to announce it has signed a Memorandum of Understanding (MOU) with Indonesia Stock Exchange (IDX). The partnership will explore opportunities across a number of strategic areas that seek to support the mutual development of both organisations and their corresponding markets.
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023
Total revenues increase by 36.3% year-over-year; gross margin improves to 77.7%; balance sheet remains robust. Company's PIKA rabies vaccine approved for Phase III clinical trials in Singapore, the Philippines, and Pakistan; interim results expected early next year
Big Pharma Bets Big on China
Western drugmakers have aligned themselves with Beijing’s health priorities and are tapping local startups for innovative medicines
Biogen to Acquire Reata Pharmaceuticals
Biogen Inc. (Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. (Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion.
境外上市备案制第一家赴美国IPO获「备案通知书」，新骏羊绒服饰拟纳斯达克上市
Shanghai-based Majestic Ideal Holdings Limited is the first Chinese company to receive a green light from China's CSRS to be listed in the US, since the government agency published new rules for offshore listings on March 31.
Singapore’s Mirxes to List in Hong Kong After Securing $50M in Series D Funding
Mirxes Holding Company Limited, a Singapore-headquartered biotech firm, announced Tuesday that it has filed listing application with The Stock Exchange of Hong Kong Limited after securing $50 million Series D funding.
